FT4/FT3与急性冠脉综合征患者术后支架内再狭窄的相关性研究  

Study on the Correlation of FT4/FT3 with Postoperative In-Stent Restenosis in Patients with Acute Coronary Syndromes

作　　者：霍兰英 纪翠玲[2] 

机构地区：[1]济宁医学院临床医学院,山东 济宁 [2]济宁医学院附属医院心血管内科,山东 济宁

出　　处：《临床个性化医学》2024年第4期2393-2399,共7页Journal of Clinical Personalized Medicine

基　　金：济宁市重点研发计划项目(2023YXNS202)。

摘　　要：目的:探讨甲状腺素/游离三碘甲状腺原氨酸(free thyroxine/free triiodothyronine, FT4/FT3)与急性冠脉综合征(acute coronary syndrome, ACS)患者接受经皮冠状动脉介入(percutaneous coronary intervention, PCI)治疗后发生支架内再狭窄(in-stent restenosis, ISR)的相关性,为ACS患者PCI术后出现支架内再狭窄提供一定的参考。方法:回顾性分析于济宁医学院附属医院行冠状动脉支架置入术,并于2021年1月至2022年12月来院复查造影的476例患者的临床资料,根据复查冠脉造影结果将其分为ISR组257例和非ISR组219例。比较两组患者基础资料,通过多因素Logistic回归分析明确冠心病患者发生ISR的影响因素,采用受试者工作特征(ROC)曲线分析FT4/FT3对冠脉支架置入后患者发生ISR的预测价值。结果:ISR组中高血压的患者比例、LDL、FT4/FT3水平高于非ISR组(P Objective: To investigate the correlation between thyroxine/free triiodothyronine (FT4/FT3) and in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). The correlation between PCI and ISR in patients with ACS was analyzed to provide a reference for the occurrence of in-stent restenosis in ACS patients after PCI. Methods: We retrospectively analyzed the clinical data of 476 patients who underwent coronary stenting at the Affiliated Hospital of Jining Medical College and came to the hospital for follow-up angiography from January 2021 to December 2022, and classified them into 257 cases in the ISR group and 219 cases in the non-ISR group according to the results of follow-up coronary angiography. Comparing the basic data of patients in the two groups, we clarified the influencing factors for the occurrence of ISR in patients with coronary artery disease by multifactorial Logistic regression analysis, and analyzed the predictive value of FT4/FT3 for the occurrence of ISR in patients after coronary stent placement by using the subject's work characteristics

关 键 词：冠心病 FT4/FT3 支架内再狭窄 

分 类 号：R54[医药卫生—心血管疾病]